Trial Profile
A trial to compare antiviral efficacy between tenofovir (TDF) monotherapy and TDF-based combination therapy as a rescue therapy for chronic hepatitis B with resistance to antiviral agents
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Lamivudine (Primary) ; Telbivudine (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 13 May 2016 New trial record
- 17 Apr 2016 Interim results (n=847) presented at The International Liver Congress™ 2016